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Data Extraction And Management In Networks Of Observational Health
Care Databases For Scientific Research: A Comparison Among EU-ADR,
OMOP, Mini-Sentinel And MATRICE Strategies
Abstract
Introduction: We see increased use of existing observational data in order to achieve fast and transparent
production of empirical evidence in health care research. Multiple databases are often used to increase power,
to assess rare exposures or outcomes, or to study diverse populations. For privacy and sociological reasons,
original data on individual subjects can’t be shared, requiring a distributed network approach where data
processing is performed prior to data sharing.
Case Descriptions and Variation Among Sites: We created a conceptual framework distinguishing three
steps in local data processing: (1) data reorganization into a data structure common across the network; (2)
derivation of study variables not present in original data; and (3) application of study design to transform
longitudinal data into aggregated data sets for statistical analysis. We applied this framework to four case
studies to identify similarities and differences in the United States and Europe: Exploring and Understanding
Adverse Drug Reactions by Integrative Mining of Clinical Records and Biomedical Knowledge(EU-
ADR),Observational Medical Outcomes Partnership(OMOP), the Food and Drug Administration’s (FDA’s)
Mini-Sentinel, and the Italian network—the Integration of Content Management Information on the
Territory of Patients with Complex Diseases or with Chronic Conditions (MATRICE).
Findings: National networks (OMOP, Mini-Sentinel, MATRICE) all adopted shared procedures for local
data reorganization. The multinational EU-ADR network needed locally defined procedures to reorganize its
heterogeneous data into a common structure. Derivation of new data elements was centrally defined in all
networks but the procedure was not shared in EU-ADR. Application of study design was a common and
shared procedure in all the case studies. Computer procedures were embodied in different programming
languages, including SAS, R, SQL, Java, and C++.
Conclusion: Using our conceptual framework we found several areas that would benefit from research to
identify optimal standards for production of empirical knowledge from existing databases.
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and sociological reasons, original data on individual subjects can’t be shared, requiring a distributed 
network approach where data processing is performed prior to data sharing.
Case Descriptions and Variation Among Sites: We created a conceptual framework distinguishing three 
steps in local data processing: (1) data reorganization into a data structure common across the network; 
(2) derivation of study variables not present in original data; and (3) application of study design to 
transform longitudinal data into aggregated data sets for statistical analysis. We applied this framework 
to four case studies to identify similarities and differences in the United States and Europe: Exploring 
and Understanding Adverse Drug Reactions by Integrative Mining of Clinical Records and Biomedical 
Knowledge(EU-ADR),Observational Medical Outcomes Partnership(OMOP), the Food and Drug 
Administration’s (FDA’s) Mini-Sentinel, and the Italian network—the Integration of Content Management 
Information on the Territory of Patients with Complex Diseases or with Chronic Conditions (MATRICE).
Findings: National networks (OMOP, Mini-Sentinel, MATRICE) all adopted shared procedures for 
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Introduction
Observational studies based on secondary use 
of existing data collected in the process of health 
care delivery have the potential to deliver sound 
evidence quickly enough to support health policy 
making, which it is often subject to time constraints 
[Salmon2012],1 thus complementing evidence 
generated by means of primary data collection. 
However, some epidemiological questions, especially 
those concerning rare events, rare exposures, and 
small groups of patients, require more data than is 
available in any single observational database.2,3,4 
Therefore a growing number of studies use data 
from networks of databases, sometimes from 
different countries. Although some of these 
networks were formed ad hoc for a particular study, 
several more permanent networks have now been 
established, where the partners have agreed on 
an infrastructure and workflow to be reused for 
different studies.
Privacy regulations and concerns about data 
ownership and interpretation prevent easy central 
pooling of original health care data that is now 
stored in different databases and can be used for 
secondary purposes.5 In spite of these barriers 
several approaches can be used to still employ this 
data for secondary purposes and pool the results. 
For example, investigators at each data source can 
independently create a protocol and execute the 
study, and estimates are only generated afterward 
through meta-analysis. A further step is to share the 
protocol across sites, but asking the local partners 
to adapt it to their local data and to implement it in 
their own usual software, to produce local estimates 
for meta-analysis that are compatible by design. 
However, most networks now go even further 
and adopt a distributed analysis approach: each 
database is locally transformed to a representation 
that is similar across the network, and one single 
computer program performing the analysis is shared 
and executed at each site.4,6
The need to pool data across different databases 
is most pronounced in the area of drug safety 
surveillance.7 In Europe, the Exploring and 
Understanding Adverse Drug Reactions by 
Integrative Mining of Clinical Records and Biomedical 
Knowledge Project (EU-ADR)8,9 was initiated in 
2008 for investigating the feasibility of signal 
detection across multiple health care databases. 
design was a common and shared procedure in all the case studies. Computer procedures were 
embodied in different programming languages, including SAS, R, SQL, Java, and C++.
Conclusion:8VLQJRXUFRQFHSWXDOIUDPHZRUNZHIRXQGVHYHUDODUHDVWKDWZRXOGEHQHŚWIURPUHVHDUFK
to identify optimal standards for production of empirical knowledge from existing databases. an 
opportunity to advance evidence-based care management. In addition, formalized CM outcomes 
assessment methodologies will enable us to compare CM effectiveness across health delivery settings.
CONTINUED
2
eGEMs (Generating Evidence & Methods to improve patient outcomes), Vol. 4 [2016], Iss. 1, Art. 2
http://repository.edm-forum.org/egems/vol4/iss1/2
DOI: 10.13063/2327-9214.1189
Volume 4 (2016) Issue Number 1
Meanwhile, the United States Food and Drug 
Administration’s (FDA’s) Mini-Sentinel Project10 
was developed to support medical product safety 
monitoring and now includes 18 data partners 
within a distributed network. Also in the United 
States, from 2010 to 2014 the Observational 
Medical Outcomes Partnership (OMOP)11 performed 
methodological research on drug safety studies 
and developed tools and a database network for 
performing risk identification. Other networks 
have been developed in other countries, like the 
Canadian Network for Observational Drug Effect 
Studies (CNODES) project in Canada and the 
Asian Pharmacoepidemiology Network (ASPEN) 
network in Asia.4 Pharmacoepidemiology is not the 
only field where the opportunities for combining 
multiple databases are increasing: in the context 
of public health or health services research, 
gathering data from different regions or countries 
has the added value that different policies can 
be compared. Mini-Sentinel and EU-ADR are also 
used to evaluate the impact of regulatory actions.
And the Italian network—the Integration of Content 
Management Information on the Territory of Patients 
with Complex Diseases or with Chronic Conditions 
(Integrazione dei Contenuti Informativi per la 
Gestione sul Territorio di Pazienti con Patologie 
Complesse o con Patologie Croniche)(MATRICE) 
Project,12,13 funded by the Italian Ministry of Health—
created a distributed network to evaluate the impact 
of health policies on quality and equity of health 
care.
We developed a conceptual framework to analyze 
the process of data management in a network 
of databases adopting the distributed analysis 
approach to perform observational studies. We 
applied the framework to four case studies, and 
identified similarities and substantial differences.
Purpose and Target of This Study
The purpose of this study was to compare processes 
that share the same aim but are presently described 
in separate scientific papers or other documents. 
Our intent was to find which choices were common 
among different networks and what the differences 
were. The comparison findings highlight topics 
for research. Research should be aimed to further 
explore if common choices are indeed optimal, and 
to assess which among the observed differences 
have an impact on the quality of the processes and 
on the generated evidence: as such, our findings may 
be of interest for researchers in medical informatics 
and methodologists of observational studies. 
Moreover, the framework and the findings from 
the comparison provide a unified presentation of 
strategic choices that are of interest to researchers 
who are setting or modifying their own networks.
Methods
Sampling and Data Collection
Some of the paper’s authors first conceived of the 
conceptual framework as an abstraction of the 
process in place in the European network EU-ADR 
and in the Italian network MATRICE. They reached 
out to the authors participating in the United States 
networks OMOP and Mini-Sentinel, to compare 
networks of different continents. Data collection 
was performed via document (scientific papers and 
websites) analysis and interviews with coauthors. 
The manuscript was reviewed by all the authors.
The Four Networks
The EU-ADR Project was funded by the European 
Commission under Framework Programme 7 
(FP7) and ran from 2008 to 2012 with the aim 
of producing a computerized integrated system 
for the early detection of drug safety signals. The 
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project used data from eight databases from 
four European countries (Denmark, Italy, the 
Netherlands, and the United Kingdom) covering a 
population of about 20 million individuals overall 
with almost 60 million person-years (PYs) of 
follow-up.3 Subsequently, the EU-ADR workflow 
has been further improved and applied in several 
collaborative drug-safety studies concerning NSAIDs 
(SOS),14,15 pandemic influenza vaccine (VAESCO),16 
the arrhythmogenic potential of drugs (ARITMO),17 
and hypoglycemic drugs (SAFEGUARD).18 The 
subjects of the studies performed in this network 
include methodology19,20,21,22 drug utilization, disease 
incidence,23 signal detection,24 testing,25,26 filtering,27 
and substantiation.28 The workflow is currently being 
extended in the European Medical Information 
Framework (EMIF) project.29
The United States FDA’s Mini-Sentinel program30 
began in 2008 and has created a distributed data 
network of 18 data partners covering a population 
of over 150 million persons and 380 million PYs in 
the United States [Curtis2012].6 Mini-Sentinel was 
structured to produce both fast, standardized replies 
to specific queries (called Rapid Response queries 
[MiniSRRQ2013, MiniMP2013]) and studies based 
on ad hoc developed protocol (i.e., Protocol-based 
Assessments [MiniPBA2013]). Hundreds of Rapid 
Response queries are executed each year, and 14 
Protocol-based Assessments have been completed 
or are underway. Network activities cover a broad 
range of topics including drug utilization, disease 
burden, the impact of regulatory policies, and the 
comparative safety of medical products.31 At the 
same time, several studies focusing on methodology 
have been completed.32,33,34,35,36,37 In 2015 the Mini-
Sentinel pilot transitioned to the Sentinel system that 
is become part of the FDA’s regulatory framework.
OMOP was a public-private partnership that ran 
from 2010 to 2014 and was part of the Innovation 
in Medical Evidence Development and Surveillance 
(IMEDS) program of the Reagan-Udall Foundation 
for the FDA. Its goal was to help determine best 
practices for use of observational health care 
data. OMOP currently maintained five commercial 
databases covering 164.9 million persons in its own 
central venue, and its data partner network included 
six other databases covering an additional 105 million 
persons [Stang2010.8,38 The network was used to 
develop tools for performing observational studies in 
a database network, including the OMOP Common 
Data Model (CDM),39 the OMOP Vocabulary,40 and 
tools for assessing data quality,41 as well as research 
into the development and evaluation of methods 
for drug-associated risk identification.42 In 2014 the 
OMOP research team launched the Observational 
Health Data Sciences and Informatics (OHDSI) 
(pronounced “Odyssey”) program43 which is 
currently continuing the activity of OMOP.
The MATRICE project was funded by the Italian 
Ministry of Health and ran from 2011 to 2014 under 
the coordination of the Italian National Agency for 
Regional Health Services to measure quality of health 
care for chronic diseases. MATRICE developed a 
distributed network infrastructure specific to local and 
regional Italian administrative databases and is rapidly 
growing to include participants beyond the project. 
Currently, it covers a population of about 9 million 
subjects living in some of the Local Health Authorities 
in 9 of the 21 regional health care systems in the 
country. Studies completed so far using data from 
this network were aimed at evaluating the quality 
and equity of primary care, the impact of policies 
in this field [Visca2013,44,45,46,47 and methodological 
challenges of such studies [Gini2014].48,49 The network 
currently participates in several studies funded by the 
Italian Ministry of Health.
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Conceptual Framework
Figure 1 depicts our conceptual framework, showing 
a workflow consisting of data sets (D1, D2, D3, and 
D4) and transformation processes (T1, T2, and 
T3). The conceptual framework does not contain 
recommendations in itself: it is just a conceptual 
abstraction of the logical sequence of steps needed 
to perform studies in a network.
Figure 2 describes each step in detail. During a 
typical study, data transformation T2 and T3 might 
be performed iteratively: if additional analyses are 
required to shed light on preliminary results, then T3 
or both T2 and T3 can be repeated and new D4 can 
be produced to undergo statistical analysis. In some 
studies T2 (data derivation) may not be performed, 
if data needed for the study are all contained in the 
original data.
To ensure that T1–T3 are valid, both in terms of how 
well the transformation reflects the original data and 
of whether it achieves the aim of the transformation, 
quality control processes need to be in place. In 
Box 1 process and outcome verification steps are 
highlighted.
D1, D2, D3, and D4 represent data sets; T1, T2, and T3 represent data transformations.
D1 
ORIGINAL 
DBs
D4 
DATA SETS 
FOR 
ANALYSIS
D2 
GLOBAL 
SCHEMA
D3 
DERIVED 
DATA
T1 
REORGANIZATION
T2 
DATA DERIVATION
T3 
STUDY DESIGN 
APPLICATION
Figure 1. Flowchart of the Data Transformation Process Occurring Locally in a Study Collecting Data 
from a Network of Databases
Box 1. Definition of the Conceptual Framework
DATA SETS AND DATA TRANSFORMATIONS:
D1 (original databases: DBs) is a collection of data sources controlled by a single organization that has 
procedures in place to link them with each other at the individual level, thus creating a single data pool 
on the same subjects. The term “DB” refers to an organization that has access to the data.
T1 (data reorganization) is a data modeling step: transformation from the locally defined data repository 
into a global (common) schema with standardized variable and attribute names, without loss of 
information. Simple one-on-one recoding is performed as well, such as making data formats and coding 
of attributes (e.g., gender) identical. T1 is specific per DB but independent of the specific study.
D2 (global schema, GS) is a general database schema that contains all the attributes thatare necessary 
to answer a realm of study questions (“use cases”) that are of general interest to the network, 
such as incidence of disease, drug utilization, or association studies. D2 has a defined set of table 
names, attribute names, and formats. D2 plays the same role as a GS of a data integration system.50 
Therefore, a set of correspondences are defined between this schema and the D1. Note that (1) these 
correspondences may not be complete for all databases: for instance, if a D1 does not have information 
about primary care diagnoses, these attributes will remain empty in the D2; and (2) some attributes 
(typically, diagnoses or drugs) might have different coding for different DBs in the network.
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Box 1. Definition of the Conceptual Framework (Cont’d)
DATA SETS AND DATA TRANSFORMATIONS (CONT’D):
T2 (data derivation) is the step where novel meaning is obtained from D2 by means of an explicit 
manipulation and combination of D2data. These manipulations are necessary when a study variable is 
not among those collected by one of the DBs in the network, and must therefore be represented, by 
proxy, as a combination of whatever pertinent information is available. When the study variable is a 
disease, this process is referred to in the literature as disease phenotyping.51 T2 is often specific per DB, 
as it depends on the information that was originally collected, and is often specific per study, although 
conceivably past data derivations could be reused in new studies. As an example of T2, if the presence 
of diabetes in study subjects needs to be assessed, DBs collecting data from primary care can identify 
the information from a general practitioner’s (GP’s) diagnosis, whereas claims databases without clinical 
data from primary care may use dispensing of antidiabetic drugs as proxy, and combinations may also 
be possible.
D3 (derived data) are the data sets derived in T2, each containing one or more study-specific 
variables. Derived data may be occurrence of a disease, or other information like the duration of 
exposure to a specific drug. For instance a drug safety study has three basic types of derived data: 
the outcome of interest (often sudden occurrence of a condition), the exposure (a sequence of drug 
utilization episodes), and presence in the study cohort, with beginning and end dates of follow-up. 
While the tables forD2 contain multiple, longitudinal observations per subject, each generated during 
an encounter and each containing multiple codes, D3 contains as many observations per subject as 
requested by the study design (often one single observation). Original data (as modeled in D2) is 
therefore “rolled up”during T2 to create in D3 the best possible approximation of the variables needed 
in the specific study.
T3 (study design application) is data transformation for a specific analytic: based on the protocol 
of a study with specific design (application of inclusion and exclusion criteria, selection of exposure 
windows, propensity and disease score estimation, control selection, matching). T3 produces the data 
sets for statistical analysis. Within this transformation data may be de-identified and aggregated to 
various levels. T3 is specific to the study, butis the same across participant DBs.
D4 (data sets for analysis) is the result of T3. D4s from all the partners in the network are similar. Based 
on the level of sharing that is allowed, D4 may stay local at the database custodian or be pooled in a 
central repository. In both situations, statistical analysis on D4 follows and produces estimates to be 
interpreted.
QUALITY:
1. 3URFHVVYHULřFDWLRQ assuring quality, transparency and reproducibility of the stepwise data 
extraction process, e.g., common standard process documentation, process automatization with 
common use of dedicated software, and parallel programming; and
2. 2XWFRPHYHULřFDWLRQ checking intermediate and final output against standards, including the following:
• Benchmarking of D3 (derived data) against external data (e.g., determining whether observed 
disease rates are in line with those reported in literature);
• Benchmarking of D3 within the network (comparison of DB-specific output to assess 
homogeneity);
• Validation of D3 using a gold standard (e.g., chart review) to assess performance of data derivation 
(e.g., positive predictive value); and
• Validation of D4 using expected results (i.e., using a reference set of known causal or noncausal 
associations).
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To illustrate the steps of the workflow, an example 
from the MATRICE network is shown in Box 2.
Box 2. An Example of Data Management in the MATRICE Network
The Italian National Agency for Regional Health Services promoted a study to assess whether 
regional Italian administrative databases can be used to measure whether patients with Chronic 
Obstructive Pulmonary Disease (COPD) are treated with recommended therapies. The study 
objective was to establish whether different cohorts, defined with different case-identification 
strategies, resulted in consistent estimates of therapy adherence. The MATRICE network was used 
for this study.
Five regions were involved in the study. In each Italian region several tables of administrative data 
are collected with content regulated by national law, in particular the following: the list of residents 
(citizens and regular migrants) entitled to receive health care; hospital discharge records, with six 
diagnosis codes; exemptions from copayments for health care; and drug prescriptions. In each 
region participating in the study, a copy of the four tables (D1) was stored, with different data 
models and format. The MATRICE network has established a specific data model for the above 
mentioned four tables(list of residents; hospital discharge records; exemptions from copayments 
for health care; and drug prescriptions), and the format is flat comma-separated files (D2).
Two of the regions had already participated in a previous study of the MATRICE network, so T1 had 
already been performed. In the other three regions, the format D2 was explained to a local expert 
by means of structured documents and a teleconference, a common software named TheMatrix 
was installed (see “T1 (reorganization)” inthe “FINDINGS” Sectionbelow), and T1 was performed by 
the local expert and was checked with standard procedures embedded in the software.
The study protocol had defined several variables to be extracted or derived: gender, presence in 
the region at index date, age at index date, presence of a COPD diagnosis in the 1–5 years before 
index date, presence of some patterns of utilization of respiratory drugs in the 1–3 years before 
index date, and adherence to recommended therapies during follow-up. D3 was composed ofa 
group of data sets, one per derived variable, each with a single observation per subject. Since in 
MATRICE all the participating data partners share the same data content (see “D1: original DBs” in 
the “FINDINGS” Section below), the transformation T2 was uniform across data partners. T2 was 
therefore embedded by the principal investigator in a single ad hoc procedure of the software 
TheMatrix, shared with the local partners and executed locally.
The data set D4 was designed in the protocol to be the aggregated data set that counted the 
frequency of each combination of the variables in D3. The transformation T3 was embedded by 
the principal investigator in another ad hoc procedure of the software TheMatrix, shared with the 
local partners and executed locally.
The D4s produced by the five regions were shared with the principal investigator, who executed 
the statistical analysis of the pooled data set using the statistical software Stata 13.1.
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Findings
We describe and compareT1–T3 and D1–D4 in the 
four networks.
D1 (Original DBs)
We use “DB” to refer to an organization that has 
access to the data. Table 1 summarizes the DBs 
participating in the four networks. For each network 
a column represents a combination of data sources 
that are linked in at least one database. We classified 
data sources according to their provenance, and we 
indicated the data items available in the DB from 
that data source. If more than one DB in a network 
share the same combination, only one column is 
shown: the number of columns fora network in Table 
1 is therefore a measure of heterogeneity of the DBs 
participating in the network. MATRICE has a single 
combination (M1), EU-ADR has seven (EU1–EU7), 
Mini-Sentinel has three (MS1–MS3), and OMOP has 
four (O1–O4).
Differences and Similarities
First, in the two United States–based networks 
(OMOP and Mini-Sentinel) almost all databases 
(O1–O3 and MS1–MS3) obtain administrative 
information from primary, secondary, and inpatient 
care, while in both European networks (EU-ADR 
and MATRICE) each database lacks at least one 
setting. Second, EU-ADR pools data from the most 
heterogeneous databases: the eight databases 
showed seven different combinations. Third, in Italy, 
although administrative information from secondary 
care (such as specialty of the physician visiting the 
patient) is available, it does not contain diagnostic 
codes (M1 andEU1–EU2). Fourth, access to laboratory 
test results is rare among databases in all networks. 
Fifth, in all but one United States database, 
enrollment of subjects in the data collection is due 
to the eligibility criteria for social insurance or an 
insurance company, while in Europe criteria include 
geographical residence or being listed with a GP. 
Sixth, only in EU-ADR and Mini-Sentinel are death 
and immunization registries available. Finally, only 
Mini-Sentinel involves partners collecting information 
from both clinical and administrative data sources. 
This is achieved by integrated delivery systems that 
operate medical facilities from which they collect 
electronic health care records data.
In addition, all the partners of Mini-Sentinel and 
some partners of the other networks can access 
full-text medical records for chart validation for their 
population.
Box 3 is a fictional example of the impact of the 
differences in D1 on the information captured from a 
patient history.
T1 (Reorganization)
In Table 2, T1 is compared across case studies.
Differences and Similarities
Besides local storage, in OMOP some databasesalso 
allow creating a central and cloud-based copy of the 
transformed data. In MATRICE and Mini-Sentinel, all 
original databases used the same coding systems, 
while in OMOP participating databases used 
different coding systems and even unstructured free 
text in different languages, in EU-ADR.
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Different strategies were adopted to transform the 
original data into a common data set: in EU-ADR, 
the transformation T1 was used only in internal 
discussions to define T2, and data sets in the 
common data model were never created.
In MATRICE, standard procedures for T1 are in place, 
and results are evaluated by local partners. In Mini-
Sentinel, data is transformed to a general, common 
data model andis updated frequently; and checks 
for data completeness and consistency with the 
data model are Standard Operating Procedures 
(SOP) executed as part of each transformation 
and approval process.52 OMOP recoded all data 
to a single system during T1, independently of a 
study question, the transformation in T1 is evaluated 
by first generating descriptive statistics of all 
elements in D2 using a tool called Observational 
Source Characteristics Report (OSCAR), and by 
subsequently performing internal and external 
comparison of these statistics using a tool called 
Generalized Review of OSCAR Unified Checking 
(GROUCH). Both in OMOP and Mini-Sentinel, a 
formal Extraction, Transformation, and Loading 
(ETL) document is created as part of development 
and implementation of the data model. In MATRICE 
the transformation is executed via ad hoc software, 
called TheMatrix,53 whose configuration is stored in a 
text file.
Box 3. A Short Illustration of the Differences in Original Data
In 2005, Irina, age 36, developed gestational diabetes during her second pregnancy, which was 
diagnosed by her gynecologist and treated with insulin prescribed by her GP. Irina gave birth to 
Louise in a hospital, and had her vaccinated against tetanus and diphtheria when the baby was six 
months old. The following year Irina’s father Mario, age 67 and a smoker with a history of coronary 
heart disease, moved to the region where Irina lived. In 2007, Mario was diagnosed with diabetes 
by his GP, who was also his daughter’s GP. After trying for a while to cope with his condition only 
through following a new diet, he started taking antidiabetic drugs in 2008. In 2010 he had severe 
angina and was admitted to the hospital for a few days. In 2013 Mario died in his sleep, and his 
death certificate indicated that the cause of death was myocardial infarction.
If Irina, Louise, and Mario were part of the database population of the four networks, the image 
of the story would be different. For databases lacking diagnosis from primary or secondary care, 
like M1 or EU1–EU4, Irina’s beginning to take insulin could be misinterpreted as an occurrence of 
diabetes, even though a complex algorithm using hospital admittance for delivery or the ending of 
insulin prescriptions could effectively avoid misclassification. Louise’s vaccine would be detected 
by MS1, MS2, and MS3. When Mario moved to Irina’s region and entered the database population, 
only databases collecting clinical history from primary care—like EU6, EU7, MS1, and O4—could 
have detected that he was the father of Irina and was a smoker. While the history of coronary heart 
disease could also be deduced from the same databases or clinical notes of a cardiologist in MS1, 
the presence of the disease may be inferred from drug utilization data in all the databases, and 
angina precisely in 2010 in databases with diagnoses from inpatient care (MA1, EU1–EU4, all MS, 
and O1–O3). Diabetes would be detected in 2007 from primary care diagnosis in EU5–EU7 and all 
the United States databases, and in 2008 only from drug utilization in the others. Occurrence of 
myocardial infarction would be detected only by EU2, EU3, and all the MS databases.
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Table 2. Comparison with Respect to T1, D2, T2
T1 (DATA REORGANIZATION)
NETWORK RECODING
QUALITY:  
DATA COMPLETENESS
QUALITY:  
DOCUMENTATION
EU-ADR Does not require 
mapping to external 
standard: original coding 
and/or free text is 
maintained
Demanded to local 
partners, no formal 
procedure
No formal documentation
Mini-
Sentinel
Source data are 
homogeneous in coding 
systems
Local report on specific 
issues + feedback 
from standard 
programs checking 
for completeness and 
consistency
Data model, data elements 
and guiding principles 
approved by partners. ETL 
formal document, ad hoc 
per DB
OMOP Source data standardized 
to common vocabulary 
by domain: Drug 
(RxNorm), Condition 
(SNOMED), Labs (LOINC)
Formal procedures: 
OSCAR and GROUCH 
tools
ETL formal document,  
ad hoc per DB 
MATRICE Source data are 
homogeneous in coding 
systems
Formal procedures 
checking data 
completeness
Local configuration of  
the TheMatrix software 
(text file) 
D2 (GLOBAL SCHEMA)
NETWORK
NAMES OF  
TABLES CHOSEN  
ACCORDING TO
NAMES OF  
ATTRIBUTES  
CHOSEN  
ACCORDING TO
EVERY TABLE 
OF THE CDM 
HAS A VIEW IN 
EVERY DB
ATTRIBUTES 
ARE CODED 
UNIFORMLY 
ACROSS DBS
EU-ADR Reason/setting of data 
recording
Clinical contents N N
Mini-
Sentinel
Clinical content and 
data source (diagnosis, 
procedures, encounters, lab 
results) or reason/setting 
(outpatient pharmacy, 
death, enrollment) 
Reason/setting of data 
recording for diagnosis 
and similar, clinical 
contents for pharmacy 
and death
N Y
OMOP Clinical content Reason/setting of data 
recording 
Y Y
MATRICE Reason/setting of data 
recording
Clinical contents Y Y
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In Table 2, D2 is compared across case studies.
Differences and Similarities
The main difference we observed in the evaluation of 
the data models was the way two main characteristics 
of an encounter were captured: the setting where 
the health care was administered (e.g., general 
practice, inpatient care, laboratory) and the medical 
content of the encounter (e.g., diagnosis, procedure, 
laboratory test). One possibility was that information 
was grouped in tables according to the setting (e.g., 
a table for hospital admissions, another for laboratory 
tests) and facts were recorded as attributes. The 
alternative was that encounters were grouped in 
tables defined by medical content (e.g., a table for 
diagnoses, a table for procedures) and the care 
setting was recorded as an attribute. EU-ADR and 
MATRICE adopted the first approach, OMOP adopted 
the second, and Mini-Sentinel adopted a combination 
of the two approaches—death and pharmacy 
dispensations were organized in the first way and 
other information was organized in the second.
Table 2. Comparison with Respect to T1, D2, T2 (Cont’d)
T2 (DATA DERIVATION)
NETWORK LOGIC
SINGLE  
DEFINITION PER 
DERIVED DATA
QUALITY:  
PROCESS  
CONTROL
QUALITY:  
VALIDATION
EU-ADR DB-specific 
algorithms, 
harmonized through 
a formal negotiation 
process
Y No common 
procedures were 
implemented., 
although logic of 
local procedures 
was shared
Internal incidence rates 
comparison, comparison 
with literature, some 
validation with external 
gold standard (PPV)
Mini-
Sentinel
The same algorithm 
was used across all 
DBs
Y Shared SAS script Systematic review of 
previously published 
validation studies, 
expert clinical, data, and 
epidemiologic guidance, 
medical chart review for 
PPV and assessment of 
difference in dates
OMOP Multiple alternative 
algorithms were 
adopted to derive 
the same data, 
some were DB-
specific
N Shared 
parameterized SQL 
queries stored in 
common procedure 
(RICO)
Internal prevalence rates 
comparison, no external 
validation performed
MATRICE Multiple algorithms 
were explored, 
decision was taken 
by means of a 
validation study
Y Shared script in a 
scripting language 
developed ad hoc 
(TheMatrix)
Validation of algorithms 
with external gold 
standard: sensitivity, 
specificity, PPV, NPV
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In Table 2, T2 is compared across case studies.
Differences and Similarities
In EU-ADR each data custodian executed its 
algorithm with its own usual extraction tool to derive 
simple input files for a specific study, while execution 
was performed with common software on the GS 
in the other networks. OMOP and Mini-Sentinel 
adopted shared SQL and SAS code, respectively. 
In MATRICE an ad hoc scripting language was 
designed and a compiler (a computer program that 
transforms source code written in a programming 
language into another) from this language toward 
the Java virtual machine was developed; extraction 
in a shared code was then executed locally.
Since OMOP focused on methods development, it 
often used multiple algorithms for data derivation, 
to study the impact of the differences. In MATRICE, 
ongoing validation studies test several algorithms, 
but the plan is to use a single best definition per 
study in the end.
In EU-ADR, to overcome the heterogeneity across 
terminologies, a shared semantic foundation was 
built by using Unified Medical Language System 
(UMLS) concepts to define events5. Then, the 
definitive choice of algorithms was obtained through 
an iterative negotiation between databases: DBs 
with similar structures were invited to query the 
same tables and fields.54 In Mini-Sentinel, algorithms 
are developed (or reused) for specific analyses and 
applied at the time of analysis; the result of those 
algorithms is not stored in the database, but analytic 
files for each assessment are retained locally.
As for validation of the event resulting from data 
derivation, all the networks compared incidence- 
or prevalence rates among databases as a tool to 
assess consistency. OMOP did not routinely compare 
with external standards nor with the literature. The 
other networks performed either population-based 
external validation to estimate all validity indices 
(MATRICE) or external validation of a random 
sample of automatically detected events to estimate 
positive predictive value (EU-ADR, Mini-Sentinel).
T3 (Study Design Application)
In Table 3, T3 is compared across case studies.
Differences and Similarities
During steps T1 and T2, local partners in some of the 
networks were asked to implement the processes that 
had been agreed upon in their own local procedures; 
moreover the procedures were not shared. In step 
T3 (study design application), data transformation 
into analytical data sets was performed in all four 
networks using shared and common software. In Mini-
Sentinel and OMOP, statistical analysis was needed in 
T3 to estimate propensity and disease scores, while 
in the studies implemented in the other networks 
only simpler tasks were needed: linkage between 
different tables, time splitting, random selection, 
matching, de-identification, and aggregation. The 
software Jerboa was developed and used by EU-ADR 
to execute T3. The software TheMatrix developed by 
MATRICE executes both T2 and T3: a Domain Specific 
Language (DSL) was designed and developed for 
this purpose. DSLs are computer programming 
languages whose features and expressiveness are 
restricted and designed ad hoc to fit a given field of 
application. They target a narrower set of programs 
than general-purpose languages like Java, but in 
exchange they provide a higher level of abstraction 
and can be programmed directly by domain experts 
rather than computer programmers.55 In MATRICE, 
a DSL generating tool called Neverlang was used to 
develop the language,16,56 and scripts in the language 
were generated by domain experts.
Mini-Sentinel and OMOP both used existing software 
(SQL, SAS, C, Java and R).
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Table 3. Comparison with T3 and D4
T3 (APPLICATION OF STUDY DESIGN)
NETWORK
LOCAL  
PARTNERS 
EXECUTE 
SHARED  
PROCEDURE
COMMON 
AMONG  
DBS
SCORES  
ESTIMATION
SPECIFIC  
SOFTWARE
PROGRAMMING 
LANGUAGE
EU-ADR Y Y N Jerboa Java & Jerboa 
scripting language
Mini-
Sentinel
Y Y Y Modular programs 
and macros; 
PopMedNet 
SQL, SAS, Java, R, 
OMOP Y Y Y — SQL, SAS, R, C, Java
MATRICE Y Y N TheMatrix Java & TheMatrix 
scripting language
D4 (DATASETS FOR ANALYSIS)
NETWORK TYPE FORMAT
QUALITY: STUDY RESULTS  
VALIDATION
EU-ADR Intermediate files that can 
be shared among partners, 
analysis will follow
csv Drug safety methodology: comparison 
of observed drug-event associations 
with previously classified true and false 
causal associations; impact on this of 
different definitions of the derived data
Mini-
Sentinel
Level of granularity of dataset 
depends on study needs; 
always transfer minimum 
necessary. Some analyses 
transfer aggregate data, some 
use highly-summarized patient-
level data Intermediate files 
saved locally by data partners 
csv, SAS 
datafiles, 
HTML 
To test code known associations are 
used. Rapid Response queries include 
data characterization and are reviewed 
manually by a data expert and an 
epidemiologist. Results are also reviewed 
by data partners. Protocol-based 
assessments might include chart reviews.
OMOP Final estimates, intermediate 
files are discarded
csv, SAS 
datafiles, 
SQL 
tables 
Drug safety methodology: comparison 
of observed drug-event associations 
with previously classified true and false 
causal associations; impact on this of 
different definitions of the derived data; 
estimate of residual bias per event by 
means of known non causal associations.
MATRICE Intermediate files to be used for 
analysis or report generation
csv Results are reviewed by data partners 
for comparison with similar analysis 
performed independently
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D4 (Data Sets for Analysis)
In Table 3, D4 is compared across case studies.
Differences and Similarities
In OMOP only final estimates were shared, while in 
the other networks integrated data sets were shared 
to be pooled before statistical analysis.
EU-ADR and OMOP both adopted a similar 
validation strategy for their methodological studies 
in drug safety, which implicitly validated the whole 
sequence of data transformations at once: a set of 
positive controls (known adverse drug reactions) 
and negative controls (drug-outcome pairs that are 
believed to have no causal relationship) was created. 
The quality of each method of analysis was assessed 
by measuring its discriminating power, i.e., the ability 
of telling positive from negative controls.
Discussion
In this paper we introduce a conceptual framework 
to analyze the data management process of a 
network performing distributed analyses. By 
applying the framework to four case studies we 
identify similarities and substantial differences. With 
this as the foundation, we highlight areas that need 
further research to identify optimal strategies.
Differences in Original Databases (of DBs) Have 
Huge Consequences
The differences observed in the four networks when 
comparing the original databases (D1) are huge. 
Understanding such differences is a challenge in 
itself, as terminology describing health data sources 
is not shared across countries.57 The three national 
networks (MATRICE, OMOP, and Mini-Sentinel) were 
much more homogeneous than EU-ADR. Since we 
expect that networks will continue to grow and 
new DBs will be different from existing DBs, the 
problems that EU-ADR encountered could indicate 
challenges other networks will face in the future if 
the geographical area is extended. United States 
databases often have in- and outpatient diagnoses, 
whereas these are rarely all captured in European 
administrative databases. In contrast, in Europe 
general practice databases are very rich since in 
many countries GPs have a gatekeeper function, that 
is, nonemergency health care can be accessed free 
of charge only upon the prescription of a GP. Death 
registries are infrequently part of the data sources 
available to databases, and this hampers detection 
of conditions, like acute myocardial infarction or 
stroke, whichmay cause death before the patient can 
reach a health care facility. Due to the differences 
in available information in the different databases, 
various strategies need to be used in order to have 
a comprehensive data derivation of study variables, 
e.g., in the absence of outpatient diagnostic data, 
drug utilization or laboratory values may be used to 
identify certain conditions.
'LIIHUHQFHVLQ*OREDO6FKHPDV*6$UH1RW
Substantial
Differences in the GS (D2) between the networks 
exist but are not substantial, as each GS can be 
mapped into another, except for those data items 
that are specifically collected in a single network 
(for instance, exemptions from copayment, which 
are documented only in Italian DBs). It would be 
very valuable, however, to explicitly create such 
a mapping, as this would make it possible to run 
existing software procedures embodying T2 and 
T3 independently of the network: this happened, 
for instance, in a study replicating—in the EU-ADR 
network—results from the OMOP network.58 One 
area of research should be the impact of different 
formats of GSs on study outcomes.
Different Approaches to Terminology Mapping
In two networks (OMOP and EU-ADR), different 
disease and drug coding systems needed to be 
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managed. In OMOP the differences were addressed 
by mapping to homogeneous coding systems during 
T1, although the original codes were not discarded 
but were also included in D2. In EU-ADR, mapping 
was not conducted in T1, therefore all mapping was 
performed during T2 and only for study-specific 
conditions. Due to the large differences in the 
granularity and type of coding schemes, in European 
databases mapping was very time-consuming—yet 
this was necessary to obtain consensus across data 
custodians and investigators6—and is progressively 
growing a shared library. The impact of different 
mapping strategies, and whether mapping should be 
done at all versus addressed in the analytic phase, 
should be investigated.
6KDULQJ$JJUHJDWHG'DWD6HWV9HUVXV6KDULQJ
Estimates
If network partners can share aggregated data 
sets in D4, the investigators maintain freedom to 
perform some subset and sensitivity analysis that 
were not strictly foreseen in the protocol without 
performing a new round of transformation. Sharing 
aggregated data would allow different levels of 
pooling and potentially more power with respect to 
meta-analysis, although previous research shows no 
improved performance of one approach over the 
other.14,59,60,61 Given the privacy related issues around 
data sharing, it should be investigated when different 
levels of sharing may be indicated.
Software Tools, Professional Skills, and Information 
Technology
Software tools used during the transformation 
process differed across case studies. This had 
implications for the type of professional skills needed 
to perform studies in the network as well as the 
readability of the programs for other investigators.
In principle, all data transformations must be 
documented to allow investigators to correctly 
interpret study results and to understand study 
limitations and strengths. OMOP and Mini-Sentinel 
have complete websites where information is 
stored and can be openly accessed, while EU-ADR 
and MATRICE rely mainly on scientific papers and 
reports, a less efficient way of storing information.
How to develop transparent programs and how 
to store and share the corresponding complex 
body of information to make it easily available to 
investigators is also a relevant research topic.
9DOLGDWLRQ
Validation of derived data is an imperative condition 
to produce good epidemiological estimates,62 and 
this is even truer when heterogeneous databases 
participate ina network. Indeed, regularizing 
the process of creating research data sets from 
secondary data sets, although necessary, is not 
enough to ensure high data quality; and validation 
can quantify how much derived data fail in correctly 
identifying the study variables—failure that can differ 
across data partners.
In MATRICE—as data from primary care is lacking 
and information from secondary care is sparse—
deriving chronic conditions, the primary focus of 
the network, is cumbersome. This is why MATRICE 
is leading a population-based validation study using 
diagnosis from a sample of GPs as a gold standard. 
In Mini-Sentinel a model for a typical validation study 
was developed13 and implemented for some events, 
in particular acute myocardial infarction.14 EU-ADR 
adopted a similar study design in some validation 
studies [, Valkhoff2014].7,8 Only positive predictive 
value could be estimated from the study design 
adopted in the two networks. A similar study was 
performed on an occasional basis in OMOP.63 In 
order to estimate sensitivity, access to a population-
based data source would be required, which is more 
complex than accessing clinical charts of selected 
candidate events. However, in the specific case of 
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acute myocardial infarction, death registries are 
estimated to add from 15 percent to 25 percent of 
cases to inpatient data where both data sources are 
available6.Therefore misclassification of non-cases, 
in principle, could have a relevant impact on study 
results, especially in older subpopulations. In EU-
ADR it was observed that improving the positive 
predictive values of the outcome definition had a 
very small impact on estimates of additional risk 
of upper gastrointestinal bleeding in users of four 
drugs,7,64 and in OMOP methodological studies 
varying the definition of several outcomes had 
little impact on system performance overall,65 thus 
suggesting that outcome misclassification may not 
be a paramount concern when studying the safety 
of short exposure to drugs. This area has generated 
some research66 and deserves further study.
The only attempt to automatically incorporate the 
result of a quality procedure in the interpretation 
of study results was performed in OMOP: the 
association with an outcome observed in a set 
of drugs that are a priori known not to cause the 
outcome was computed and applied as an estimate 
of overall bias in the association of any drug with the 
same outcome.67
Designing and developing a framework that allows 
for automatically incorporating validity indices in 
study design and analysis would be a useful follow-
up for the effort invested in validation.
Epistemological Framework of Reference
Unlike in the other steps, in T3 there was a very 
similar approach in the four networks: there is a 
uniform attempt to make study designs clearly 
specified and reusable across studies. This was 
achieved in all four networks by embedding this step 
into shared software, where the same procedure was 
executed across all data sites.
It could be argued that complexity arising from the 
network setting forces investigators to specify—right 
from the study design stage —every detail of data 
management and analysis, embedded in a sequence 
of computer instructions. A priori specification of 
the detail of the experiment is at the epistemological 
core of the experimental method, as it ensures 
falsifiability.68 From this point of view, the intricacies 
of the network settings force investigators to do 
the right thing. Computer engineers have joined 
pharmacoepidemiologists and other population-
based health scientists in supporting this effort, not 
just because computer programming is needed, but 
also and most of all, because a novel, more formal 
process must be streamlined and stabilized before 
investigators take control again of the new level of 
complexity.
Limitations
The conceptual framework was useful to interpret 
similarities and differences among the four networks, 
which are heterogeneous for geographical coverage 
and purpose. However the choice of the sample of 
four was nonsystematic, therefore the framework 
may prove insufficient to include other networks in 
the comparison.
Data processing in networks of databases may 
suffer from subtle challenges: privacy laws may 
enable patients to opt out of sharing information 
based on some encounters only (for instance, for 
mental health issues); some databases may collect 
information from smaller health care providers, 
whose information is not effectively shared in digital 
form; regional or national differences in privacy 
regulations may affect differentially the partners 
of a network. We did not investigate how the four 
networks faced such challenges.
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Conclusion
We proposed a conceptual framework to analyze the 
data management process involved in observational 
studies taking place in distributed networks of 
databases. The framework was applied to four case 
studies to identify similarities and differences.
Several research questions were highlighted by this 
comparison, including interoperability among the 
available GSs, optimization of data harmonization, 
use of validity indices in study design and 
statistical analysis, development of an information 
infrastructure to support investigators in accessing 
details of data transformation, and optimal level of 
programming skills needed to manage the process.
Medical informatics is called on to support 
transparency, and quick and sound application of the 
experimental method to the production of empirical 
knowledge.
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Summary
What was already known on this topic:
• Networks of data sources are being established to 
produce observational evidence from existing data 
about diverse, ample populations; and
• Standards for data management are not 
established, so each network is adopting different 
infrastructures and procedures.
What this study added to our knowledge:
• Some steps in the data management process are 
very similar across existing networks, others are 
different; and
• Research is needed to identify optimal strategies 
and common standards.
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